Benchmarking Gemma-3-4B, MiniCPM-o 2.6, and Qwen2.5-VL-7B-Instruct for latency, throughput, and scalability.
A growing share of pharmaceutical innovation is now constrained not by scientific imagination, but by the infrastructure required to support AI at scale. In this episode of the AI in Business podcast, Thomas Fuchs, Chief AI Officer at Eli Lilly & Company, joins Matthew DeMello to explore how Lilly's new AI supercomputing platform is reshaping scientific discovery and enterprise operations....
You shouldn’t have to leave Cursor to build, deploy, or monitor a production-grade agent. You can wire together LangChain, a vector DB, a monitoring tool, and a deployment pipeline yourself, but you’ll spend more time on that plumbing than on the agent itself. DataRobot is the shortcut. It now lives where you build, integrating directly...
The post DataRobot for Developers: Skills, MCP,...
The race to production-ready agentic AI is on — but for most enterprises, the finish line keeps moving. Models get built, pilots get run, and then teams hit a wall: the infrastructure, security, governance, and operational requirements for running AI agents at enterprise scale are far more complex than any single tool or vendor anticipated....
The post Building the enterprise agentic AI...
New PULSE OF AI Podcast! Season 8, Episode 166.
Summary:
Sam Bhagwat joins podcast host Jason Stoughton in a conversation primarily about the incredible success his book "Principles of Building AI Agents" has experienced and the energy it has created among AI practitioners and aspiring AI practitioners around the globe. He emphasizes the importance of organizational design in AI...
AI agents are evolving from answering questions to taking actions inside browsers. They can now open pages, click buttons, fill forms, extract data, and automate multi step workflows across websites. Moonshot AI’s Kimi WebBridge brings this capability to Chrome and Edge, allowing local AI agents to safely interact with real browser sessions. In this article, […]
The post Kimi WebBridge:...
Every patent starts as a problem someone couldn't ignore. In 2025, SAS and JMP inventors earned 82 of them – spanning natural language processing, AI, fraud protection, IoT and more – each one rooted in the kind of friction that real organizations actually deal with. At SAS' annual Patent Dinner, [...]
The post The ideas behind SAS' patents of 2025 appeared first on SAS Blogs.
The regulatory submission process in life sciences is becoming less about assembling documents and more about proving trust. For years, submission readiness was largely treated as an end-stage operational milestone: finalize the analysis, validate the outputs and package everything for regulators. But that model is beginning to break down under [...]
The post Steps to building...
You already have an analytics platform. Your data is connected, your team uses it daily and you're getting real value from it. But AI is everywhere and someone in your business is asking the question: do we still need this, or can we just use AI instead?
On Monday, the jury in Musk v. Altman dealt Elon Musk a major blow—reaching a unanimous advisory verdict that he had sued OpenAI too late and, as a result, his claims are barred by the applicable statutes of limitations. US District Judge Yvonne Gonzalez Rogers immediately accepted it. Musk announced on X that he will…